Bellecapital International Ltd. Qiagen N.V. Transaction History

Bellecapital International Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	BUY	$42.23 - $54.3 $2,829 - $3,638	67 Added 0.39%	17,216 $850,000
Q4 2021 Jan 20, 2022	BUY	$50.62 - $56.47 $11,490 - $12,818	227 Added 1.34%	17,149 $972,000
Q3 2021 Oct 21, 2021	BUY	$46.55 - $56.83 $291,123 - $355,414	6,254 Added 58.62%	16,922 $877,000
Q2 2021 Jul 28, 2021	BUY	$46.28 - $52.75 $138,562 - $157,933	2,994 Added 39.01%	10,668 $515,000
Q1 2021 Apr 13, 2021	BUY	$46.25 - $56.02 $7,400 - $8,963	160 Added 2.13%	7,674 $356,000
Q4 2020 Jan 14, 2021	SELL	$46.09 - $54.74 $50,284 - $59,721	-1,091 Reduced 12.68%	7,514 $359,000
Q3 2020 Oct 16, 2020	BUY	$42.51 - $52.42 $142,833 - $176,131	3,360 Added 64.06%	8,605 $447,000
Q1 2020 Apr 24, 2020	SELL	$33.17 - $41.6 $582,597 - $730,662	-17,564 Reduced 77.0%	5,245 $211,000
Q4 2019 Feb 12, 2020	BUY	$25.41 - $43.1 $345,194 - $585,513	13,585 Added 147.28%	22,809 $780,000
Q3 2019 Oct 22, 2019	BUY	$32.73 - $40.81 $301,901 - $376,431	9,224 New	9,224 $315,000

6.34M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.2B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

Stay updated on Bellecapital International Ltd. with notifications on news.